Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons
- PMID: 2934045
- DOI: 10.1161/01.atv.5.6.595
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons
Abstract
We have developed a model of acute Dacron graft thrombosis in baboons in order to assess platelet alterations secondary to arterial thrombus formation. In this model, thrombus formation was initiated by Dacron vascular grafts inserted as extension segments into chronic arteriovenous Silastic shunts. Following platelet labeling with 111In-oxine, platelet deposition was measured for 1 hour following blood contact under arterial flow conditions using a scintillation camera. Graft platelet activity rapidly increased 40- to 50-fold, plateauing by 1 hour. All grafts produced equivalent reductions in circulating platelet count and blood 111In-platelet radioactivity, demonstrating that the labeled cells were functionally equivalent to the total platelet population. After graft placement, the remaining platelets survived normally. Acute platelet deposition was equivalent on grafts placed 1, 24, 48, and 72 hours following injection of the labeled cells, indicating that a variable delay between platelet labeling and graft imaging was without detectable consequence. Platelet destruction by the graft produced a tenfold increase in plasma levels of platelet factor 4 (PF4) and beta-thromboglobulin (beta TG) but did not modify either the alpha-granule (PF4, beta TG) or dense granule (ADP, ATP) contents of circulating platelets.
Similar articles
-
Thromboembolic potential of synthetic vascular grafts in baboons.J Vasc Surg. 1989 Jul;10(1):75-82. J Vasc Surg. 1989. PMID: 2526235
-
Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.J Lab Clin Med. 1989 Apr;113(4):436-48. J Lab Clin Med. 1989. PMID: 2522978
-
Induction of transient neurological dysfunction in baboons by platelet microemboli.Stroke. 1992 May;23(5):697-702. doi: 10.1161/01.str.23.5.697. Stroke. 1992. PMID: 1533737
-
Platelet factors predisposing to arterial thrombosis.Baillieres Clin Haematol. 1994 Sep;7(3):499-522. doi: 10.1016/s0950-3536(05)80096-4. Baillieres Clin Haematol. 1994. PMID: 7841598 Review. No abstract available.
-
Cardiac and vascular imaging with labeled platelets and leukocytes.Semin Nucl Med. 1984 Jul;14(3):154-87. doi: 10.1016/s0001-2998(84)80013-6. Semin Nucl Med. 1984. PMID: 6382615 Review.
Cited by
-
Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons.Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1177-81. doi: 10.1073/pnas.88.4.1177. Proc Natl Acad Sci U S A. 1991. PMID: 1996320 Free PMC article.
-
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.J Clin Invest. 1993 Oct;92(4):2003-12. doi: 10.1172/JCI116795. J Clin Invest. 1993. PMID: 8408654 Free PMC article.
-
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.Proc Natl Acad Sci U S A. 1988 May;85(9):3184-8. doi: 10.1073/pnas.85.9.3184. Proc Natl Acad Sci U S A. 1988. PMID: 3362867 Free PMC article.
-
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.Circulation. 2012 Jul 3;126(1):83-91. doi: 10.1161/CIRCULATIONAHA.112.091918. Epub 2012 Jun 15. Circulation. 2012. PMID: 22705889 Free PMC article.
-
Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal.J Thromb Thrombolysis. 1995;1(3):237-249. doi: 10.1007/BF01060733. J Thromb Thrombolysis. 1995. PMID: 10608001
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous